Non-profits play a vital role in advancing the science, education and advocacy of innovative R&D. This session unpacks how non-profits can accelerate commercialisation of products through the fast-tracking of scientific discoveries via targeted research pipelines and investment collaborative partnerships.

• Discussing Nestles’ priorities across the microbiome industry for meeting un-met patient needs and partnering with innovative biotech companies.
• Reviewing the post-market landscape of VOWST, providing lessons learnt from commercialization of an FDA approved therapeutic.